Studies from mainland China and Japan also demonstrated a low prevalence of migraine in CADASIL patients ranging from 5.3% to 27.6%, regardless of NOTCH3 mutation sites [13, 23]. This evidence concerns the gene NOTCH3 and migraine disorder.